Care Access is a clinical research site located in Warwick, Rhode Island, United States 02886.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Care Access has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2.
Sponsors: Novartis Pharmaceuticals, Novo Nordisk A/S.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Care Access has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Care Access has 2 clinical trials on record, with 1 currently active. Their work covers Primary Prevention of Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 2.
Care Access has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.